Home » Newsletters » BioWorld Science

BioWorld Science

June 30, 2017

View Archived Issues

Crestovo initiates phase III trial of CP-101 to prevent C. difficile infection

KemPharm reveals new ADHD candidate

KIAA0125 found as an unfavorable prognostic marker in acute myeloid leukemia

New zebrafish Fanconi anemia-like model developed

FDA grants orphan drug designation for ABO-201 juvenile Batten disease gene therapy program

Alcyone Lifesciences and Pfizer enter feasibility study agreement

Gene-edited hematopoietic stem/progenitor cells created for SCID-X1

Paion completes phase III program for remimazolam for procedural sedation

Alkermes reports phase III data on ALKS-3831 in schizophrenia

Auspherix patents gold complexes for treating bacterial infections

Endpoints met in Lee's phase Ib/IIa study of adapalene/clindamycin gel for acne

Merck & Co. presents oxysterols receptor LXR-beta agonists

FORWARD II finds mirvetuximab soravtansine safe in combination therapies for ovarian cancer

Luc Therapeutics discloses NMDA receptor modulators

Research Triangle Institute divulges apelin receptor agonists

Janssen Pharmaceutica discovers BTK inhibitors

Cara Therapeutics reports phase IIb topline results on oral CR-845 for osteoarthritis pain

Heptares Therapeutics and PeptiDream enter inflammatory disease collaboration

Windtree reports topline phase IIb results for Aerosurf to treat RDS in premature infants

Sanpower Group completes Dendreon acquisition

FDA grants orphan drug designation to ganaxolone for CDKL5 disorder

FDA seeks to eliminate orphan drug designation request backlog

Acorda submits NDA for Inbrija to treat off episodes in Parkinson's disease

miR15a-5p identified as a biomarker of recurrence in colorectal carcinoma

Polatuzumab vedotin is eligible for access to EMA's PRIME program

Eiger Biopharmaceuticals selling Mydicar to Theragene Pharmaceuticals

FDA grants QIDP designation to Amphora for gonorrhea and bacterial vaginosis

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...